日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real‐world analysis from 20 US centers

纳武利尤单抗联合AVD方案作为经典型霍奇金淋巴瘤患者的一线治疗:来自美国20个中心的真实世界分析

Quinquenel, Anne; Aurran-Schleinitz, Thérèse; Clavert, Aline; Cymbalista, Florence; Dartigeas, Caroline; Davi, Frédéric; de Guibert, Sophie; Delmer, Alain; Dilhuydy, Marie-Sarah; Feugier, Pierre; Fornecker, Luc-Matthieu; Ghez, David; Guieze, Romain; Laribi, Kamel; Leblond, Véronique; Leprêtre, Stéphane; Letestu, Rémi; Lévy, Vincent; Nguyen-Khac, Florence; Michallet, Anne-Sophie; Tomowiak, Cécile; Tournilhac, Olivier; Ysebaert, Loïc; Troussard, Xavier; Bock, Allison M; Hao, Peirong; Xu, Yizhe; Luttwak, Efrat; Thiruvengadam, Swetha Kambhampati; Sekaran, Kanithra; Sano, Dahlia; Vaughn, John; Sharp, John; Major, Ajay; Patel, Vrutti; Smilnak, Gordon; Araujo, Nicole; Mynam, Ritwick; Reef, Daniel; Palmeri, Marisa; Gerber, Drew; Abhyankar, Anuja; Baek, Grace; Falade, Ayo; Iqbal, Madiha; Hu, Boyu; Geethakumari, Praveen Ramakrishnan; Durani, Urshila; Di, Mengyang; Niu, Alex; Cherng, Hua‐Jay J; Rhodes, Joanna M; Grover, Natalie; Pophali, Priyanka; Feldman, Tatyana; Shanmugasundaram, Krithika; Svoboda, Jakub; Voorhees, Timothy; Diefenbach, Catherine; Karimi, Yasmin; Karmali, Reem; Herrera, Alex F; Torka, Pallawi; Epperla, Narendranath

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group

在既往未接受治疗的中危慢性淋巴细胞白血病患者中,以可测量的残余病灶为指导,比较伊布替尼联合维奈克拉与FCR方案的疗效:一项来自FILO组的II期随机试验(ERADIC)。

Quinquenel, Anne; Letestu, Rémi; Le Garff-Tavernier, Magali; Morisset, Stéphane; Subtil, Fabien; Aurran, Thérèse; Laribi, Kamel; Cymbalista, Florence; Lévy, Vincent; Simon, Laurence; Roos-Weil, Damien; Leblond, Véronique; Dilhuydy, Marie-Sarah; Tomowiak, Cécile; Dartigeas, Caroline; Guièze, Romain; Tournilhac, Olivier; Ferrant, Emmanuelle; de Guibert, Sophie; Feugier, Pierre; Merabet, Fatiha; Leprêtre, Stéphane; Carassou, Philippe; Gay, Julie; Hivert, Bénédicte; Fornecker, Luc-Matthieu; Dupuis, Jehan; Molina, Lysiane; Villemagne, Bruno; Cartron, Guillaume; Drenou, Bernard; Mahé, Beatrice; Benbrahim, Omar; Cahu, Xavier; Portois, Christelle; Ysebaert, Loïc; Nguyen-Khac, Florence; Dahmani, Abdelmalek; Quiney, Claire; Rouillé, Valérie; Delmer, Alain; Michallet, Anne-Sophie

Understanding kidney involvement in mycosis fungoides: T-cell clonality as a guide for targeted therapy - a case report and literature review

了解蕈样肉芽肿肾脏受累情况:T细胞克隆性指导靶向治疗——病例报告及文献综述

Filipović, Jelena; Maubec, Eve; Previtali, Clelia; Višić, Milica; Villette, Beatrice; Lazarian, Gregory; Letestu, Remi; Cucherousset, Joel; Soussan, Michael; Martin, Antoine

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial

慢性淋巴细胞白血病固定疗程免疫化疗方案:ICLL-07 FILO II期试验的5.5年结果

Michallet, Anne-Sophie; Letestu, Rémi; Le Garff-Tavernier, Magali; Campos, Lydia; Ticchioni, Michel; Dilhuydy, Marie-Sarah; Morisset, Stephane; Rouille, Valérie; Mahé, Béatrice; Laribi, Kamel; Villemagne, Bruno; Ferrant, Emmanuelle; Tournilhac, Olivier; Delmer, Alain; Molina, Lysiane; Leblond, Véronique; Tomowiak, Cécile; de Guibert, Sophie; Orsini-Piocelle, Frederique; Banos, Anne; Carassou, Philippe; Cartron, Guillaume; Fornecker, Luc Mathieu; Ysebaert, Loic; Dartigeas, Caroline; Truchan-Graczyk, Margot; Vilque, Jean-Pierre; Schleinitz, Thérèse Aurran; Cymbalista, Florence; Leprêtre, Stéphane; Lévy, Vincent; Nguyen-Khac, Florence; Feugier, Pierre

Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression

免疫调节恶性 B 细胞促进慢性淋巴细胞白血病进展

Arsène Mékinian, Anne Quinquenel #, Koceïla Ait Belkacem #, Feriel Kanoun, Elisabetta Dondi, Emilie Franck, Marouane Boubaya, Maïssa Mhibik, Fanny Baran-Marszak, Rémi Letestu, Florence Ajchenbaum-Cymbalista, Vincent Lévy, Nadine Varin-Blank, Christine Le Roy

Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者对mRNA抗COVID-19疫苗BNT162b2和mRNA-1273的体液免疫反应

Bagacean, Cristina; Letestu, Rémi; Al-Nawakil, Chadi; Brichler, Ségolène; Lévy, Vincent; Sritharan, Nanthara; Delmer, Alain; Dartigeas, Caroline; Leblond, Véronique; Roos-Weil, Damien; Tomowiak, Cécile; Merabet, Fatiha; Béné, Marie C; Clavert, Aline; Chaoui, Driss; Genet, Philippe; Guieze, Romain; Laribi, Kamel; Drénou, Bernard; Willems, Lise; Puppinck, Christian; Legendre, Hugo; Troussard, Xavier; Malartre, Stéphanie; Cymbalista, Florence; Michallet, Anne-Sophie

Humoral Response to mRNA Vaccines BNT162b2 and mRNA-1273 COVID-19 in Chronic Lymphocytic Leukemia Patients

慢性淋巴细胞白血病患者对mRNA疫苗BNT162b2和mRNA-1273 COVID-19的体液免疫反应

Ajufo, Helen; Vaughn, Jennifer; Bagacean, Cristina; Letestu, Rémi; Al Nawakil, Chadi; Brichler, Ségolène; Lévy, Vincent; Sritharan, Nanthara; Delmer, Alain; Dartigeas, Caroline; Leblond, Véronique; Roos-Weil, Damien; Béné, Marie C; Clavert, Aline; Chaoui, Driss; Genet, Philippe; Guieze, Romain; Laribi, Kamel; Touileb, Yamina; Drenou, Bernard; Willems, Lise; Tomowiak, Cécile; Merabet, Fatiha; Puppink, Christian; Legendre, Hugo; Troussard, Xavier; Malartre, Stéphanie; Cymbalista, Florence; Michallet, Anne-Sophie

Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia

CLL2007FMP试验的长期随访评估了氟达拉滨和环磷酰胺联合利妥昔单抗或阿仑单抗治疗既往未接受治疗的慢性淋巴细胞白血病患者的疗效。

Feugier, Pierre; Aurran, Thérèse; Mahé, Béatrice; Letestu, Remi; Nguyen-Khac, Florence; Cazin, Bruno; Tournilhac, Olivier; Maisonneuve, Hervé; Casasnovas, Olivier; Delmer, Alain; Leblond, Véronique; Royer, Bruno; Corront, Bernadette; Chevret, Sylvie; Delépine, Roselyne; Vaudaux, Sandrine; Van Den Neste, Eric; Béné, Marie-Christine; Cymbalista, Florence; Ross-Weil, Damien; Leprêtre, Stéphane

Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study

在接受氟达拉滨、环磷酰胺和利妥昔单抗治疗后,增加利妥昔单抗的暴露量并不能改善慢性淋巴细胞白血病患者的疗效和预后。法国创新白血病组织 (FILO) 的一项研究表明

Cartron, Guillaume; Letestu, Rémi; Dartigeas, Caroline; Tout, Mira; Mahé, Béatrice; Gagez, Anne-Laure; Ferrant, Emmanuelle; Guiu, Boris; Villemagne, Bruno; Letuan, Phan; Aurran, Thérèse; Orsini-Piocelle, Frédérique; Banos, Anne; Feugier, Pierre; Leblond, Véronique; de Guibert, Sophie; Tournilhac, Olivier; Dupuis, Jehan; Delmer, Alain; Rouillé, Valérie; Ternant, David; Leprêtre, Stéphane

Induction of endoplasmic reticulum calcium pump expression during early leukemic B cell differentiation

早期白血病 B 细胞分化过程中内质网钙泵表达的诱导

Lamia Aït Ghezali, Atousa Arbabian, Hervé Roudot, Jean-Philippe Brouland, Fanny Baran-Marszak, Evelyn Salvaris, Andrew Boyd, Hans G Drexler, Agnes Enyedi, Remi Letestu, Nadine Varin-Blank, Bela Papp